- Home
- AMPG vs BRTX Comparison
AMPG vs BRTX Comparison
Compare AMPG & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPG
- BRTX
- Stock Information
- Founded
- AMPG 2002
- BRTX 1997
- Country
- AMPG United States
- BRTX United States
- Employees
- AMPG N/A
- BRTX N/A
- Industry
- AMPG Telecommunications Equipment
- BRTX Managed Health Care
- Sector
- AMPG Telecommunications
- BRTX Health Care
- Exchange
- AMPG Nasdaq
- BRTX Nasdaq
- Market Cap
- AMPG 9.8M
- BRTX 11.3M
- IPO Year
- AMPG N/A
- BRTX N/A
- Fundamental
- Price
- AMPG $1.24
- BRTX $1.48
- Analyst Decision
- AMPG Strong Buy
- BRTX Strong Buy
- Analyst Count
- AMPG 1
- BRTX 1
- Target Price
- AMPG $5.00
- BRTX $18.00
- AVG Volume (30 Days)
- AMPG 139.2K
- BRTX 38.0K
- Earning Date
- AMPG 11-14-2024
- BRTX 11-12-2024
- Dividend Yield
- AMPG N/A
- BRTX N/A
- EPS Growth
- AMPG N/A
- BRTX N/A
- EPS
- AMPG N/A
- BRTX N/A
- Revenue
- AMPG $11,667,163.00
- BRTX $377,000.00
- Revenue This Year
- AMPG N/A
- BRTX $598.90
- Revenue Next Year
- AMPG $218.18
- BRTX $162.81
- P/E Ratio
- AMPG N/A
- BRTX N/A
- Revenue Growth
- AMPG N/A
- BRTX 189.55
- 52 Week Low
- AMPG $0.64
- BRTX $1.03
- 52 Week High
- AMPG $2.55
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- AMPG 70.48
- BRTX 45.13
- Support Level
- AMPG $0.78
- BRTX $1.32
- Resistance Level
- AMPG $1.00
- BRTX $1.78
- Average True Range (ATR)
- AMPG 0.12
- BRTX 0.15
- MACD
- AMPG 0.01
- BRTX -0.01
- Stochastic Oscillator
- AMPG 85.16
- BRTX 47.37
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.